Position in VKTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$43,846,738
+$10,956,079 QoQ
Shares Held
1,347,472
+44.1% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91.39173207309688.ToString("F0")%
Shared 0.ToString("F0")%
None 8.60826792690312.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Derivatives in VKTX
reported options exposure · as of Dec 31, 2025CallValue
$1,400,164
CallShares
39,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. VKTX ranks #45 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in VKTX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,846,738 | 1,347,472 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,400,164 | 39,800 | Call | Defined | 2026-01-29 | |
| 2025-12-31 | $32,890,659 | 934,925 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,839,600 | 70,000 | Call | Defined | 2025-11-13 | |
| 2025-09-30 | $35,275,852 | 1,342,308 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $25,215,464 | 951,527 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,409,337 | 596,660 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $24,874,272 | 618,148 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $20,826,393 | 328,959 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,050,837 | 359,382 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $1,404,765 | 26,500 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $22,472,592 | 274,056 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,322,299 | 339,726 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,590,880 | 143,711 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,545,909 | 157,058 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,117,078 | 187,212 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $432,850 | 46,048 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $111,702 | 41,067 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $122,260 | 42,305 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $229,086 | 76,362 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,527,939 | 332,161 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,700,711 | 270,814 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,006,493 | 168,029 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,932,881 | 305,594 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $477,980 | 84,899 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,958,237 | 336,467 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,384,209 | 330,681 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $1,828,040 | 390,607 | Shares | Defined | 2020-05-01 | |
| 2020-03-31 | $468 | 100 | Put | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||